MIAMI, FL / ACCESSWIRE / May 2, 2016 / EmergingGrowth.com - Graphene 3D Lab, Inc. (OTCQB: GPHBF) just released its quarterly report for the period ending February 29, 2016 showing an increase in revenue of 354% over their November 30, 2016 quarter.
Graphene 3D Lab, Inc. (OTCQB: GPHBF) just reported revenue for the period ending February 29, 2016 of $265,271. This is a 354% increase over the previous period ending November 30, 2015 which came in at $58,369.00.
GPHBF has been gaining gradually gaining the attention of the investment community since it announced a third line of business, the Industrial Materials Division, to be devoted to development of high volume graphene-infused polymers for the automotive, robotics, drone, aerospace and military industries.
GPHBF has also recently announced that it has been approved to move forward with the next task of its research, development and royalty agreement with a Fortune 500 listed manufacturer.
Most recently GPHBF has reported the commencement of a new production reactor that results in 5-fold increase of production capabilities of Graphene Oxide and Reduced Graphene Oxide due to expanding production volume driven by increased demand. Dr. Polyakova stated that the company is delighted to see increasing demand for its materials and committed to stay on track to satisfy this demand.
Graphene 3D Lab, Inc. (OTCQB: GPHBF) wholly owned subsidiary Graphene Laboratories, Inc. offers over 100 Graphene and related products to more than 10,000 customers worldwide including every Fortune 500 tech company and major research university.
GPHBF currently has six US Patent applications pending for its technology.
It is difficult to identify an industry with better prospects for a tremendous ROI than 3D printing.
According to Goldman Sachs (NYSE: GS), 3D printing is one of eight technologies notable as a "creative destroyer" - it will force manufacturing companies to adapt or become obsolete, while simultaneously opening new technological avenues as a highly disruptive technology.
In 2016, Hewlett-Packard (NYSE: HPQ) will look to increase its market share in its 3D Printer segment. According to a report from A.T. Kearney, the 3D printer market is expected to grow at a CAGR (compound annual growth rate) of 25% from $4.5 billion in 2014 to $17 billion in 2020. Hewlett-Packard believes that the 3D printing space will be disruptive as well as profitable in the next few years.
Ultra Petroleum Corp., (NYSE: UPL), an independent oil and gas company which engages in the acquisition, exploration, development, operation, and production of oil and natural gas properties, filed for bankruptcy protection listing $1.3 billion in assets and $3.9 billion in debt in court papers filed in Houston last Friday.
The Company, which has 159 employees cited Low commodity and natural gas prices throughout 2015 and continuing through the first four months of 2016 as the culprit.
SunEdison, Inc.'s (OTC Pink: SUNEQ) volume has subsided a bit since it's bankruptcy announcement last month.
Terra Form Power (NASDAQ: TERP) commented on SunEdison's Chapter 11 Restructuring Filing stating that SunEdison has been, and is expected to continue to be, an important partner for TerraForm Power, as SunEdison affiliates provide asset management and operations and maintenance ("O&M") services to many of TerraForm Power's power plants. TerraForm Power anticipates that SunEdison will continue to provide these asset management and O&M services for TerraForm Power's power plants following the filing. In addition, TerraForm Power expects that SunEdison generally will continue to fulfill its obligations to provide corporate level support to TerraForm Power under the Management Services Agreement between SunEdison and TerraForm Power. Even if certain of those obligations were not fulfilled, TerraForm Power expects to be able to continue operating its business pursuant to contingency plans it has been developing.
Arch Therapeutics, Inc. (OTCQB: ARTH), a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care has been traded up a bit on Friday on almost 2 million shares traded after the almost 10% drop from the release of their 10Q last Thursday.
One reason could be that the total current assets as of March 31, 2016 were $1,759,368, a decrease of $2,243,651 compared to $4,003,019 as of September 30, 2015. The company stated that the decrease in current assets is primarily attributable to general and administrative expenses resulting from intellectual property costs and research and development expenses incurred in connection with activities to develop our primary product candidate.
The company has been on a steady climb from just under .20 per share in price and volume after it obtained favorable safety data for AC5 Surgical Hemostatic Device™ in skin irritation testing in humans.
ABOUT EmergingGrowth.com:
EmergingGrowth.com focus on Emerging Growth companies that can be overlooked by the investment community. The undiscovered gems, and the smaller companies that make the large ones great, these companies can yield the highest percentage returns in the market. We look for, innovation, strategy, and execution. We specialize in growth oriented and acquisition minded companies both publicly traded and privately held. If you have an idea for an "Emerging Growth" company, drop us a line at EmergingGrowth1@gmail.com.
DISCLOSURE:
All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. EmergingGrowth.com may either hold a stock position in or have been compensated by or for a company or companies discussed in this article. EmergingGrowth.com does not have a stock position in any securities discussed in this article. Please view our full disclosure which can be found here, http://www.emerginggrowth.com/disclosure-47423/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.
CONTACT:
Company: EmergingGrowth.com - http://www.EmergingGrowth.com
Contact Email: EmergingGrowth1@gmail.com
SOURCE: EmergingGrowth.com – www.EmergingGrowth.com
ReleaseID: 439443
